Today's Rundown Amgen pays $2.7B to enlist BeiGene as Chinese R&D partner Novo drops oral GLP-1 analog to focus on next-gen Rybelsus AstraZeneca spinout Entasis nabs Shire exec as CMO [Sponsored] RenMab™ Mouse: a leading platform for fully human antibody generation Foresite unveils incubator focused on 'nexus of data science and healthcare' EuroBiotech Report—Roche-Dicerna, GSK in TB, Sanifit data, filgotinib and Novartis Chutes & Ladders—Roche taps Sause to head North American ops FiercePharmaAsia—Takeda's rare disease decline; Astellas-Pandion diabetes deal; I-Mab's Nasdaq IPO Featured Story | | | Friday, November 1, 2019 Amgen is paying $2.7 billion for a 20.5% stake in BeiGene. The investment will put BeiGene at the heart of Amgen’s efforts to develop oncology drugs for the Chinese market. |
|
|---|
|
| | White Paper: Rise in Targeted Therapies Biologics have experienced steady double-digit growth over the last 15 years. Precision medicine is also on the rise. Learn more about what to look for when navigating this new era of small-volume manufacturing. |
Top Stories Friday, November 1, 2019 Novo Nordisk has stopped development of its next-generation oral GLP-1 analog OG2023SC. The Danish drugmaker took the action after making progress with an enhanced version of its existing oral semaglutide formulation. Friday, November 1, 2019 After getting off a $75 million IPO last year, AstraZeneca’s antibiotics spinout Entasis has hired a former Shire executive to lead its R&D programs. Monday, October 28, 2019 Biocytogen uses chromosome engineering for the in situ replacement of mouse antibody genes with the human counterparts, authentic position within the chromosome. Thursday, October 31, 2019 Foresite Capital launched a new incubator working on companies at the intersection of data science and healthcare, led by its managing director and former Verily and Grail exec, Vik Bajaj, Ph.D. The firm started the incubator, dubbed Foresite Labs, to help usher in a transformation in healthcare. Thursday, October 31, 2019 In this week's EuroBiotech Report, Roche inks $200 million RNAi deal, GSK's tuberculosis vaccine shows durability and Sanifit clears phase 2b. Friday, November 1, 2019 Roche Diagnostics nabs Sause to head North American ops; Hung founds new biotech Nuvation; Sonde Health taps Liu as CEO. Friday, November 1, 2019 Sales from Takeda's rare disease business dropped on hemophilia competition and Natpara's recall. Astellas inked a Type 1 diabetes collab with Pandion Therapeutics for up to $795 million. Shanghai biotech I-Mab chose Nasdaq for its planned $100 million IPO. And more. | | QUALITY. SPEED. VALUE.
You Can Have All Three We deliver potent, picomolar-affinity, development-ready human antibodies in a greater number and a shorter timeline than other CROs using transgenic animals, in vitro display or humanization, including for difficult targets such a GPCRs. Contact us at [email protected] to learn more. alivamab.com |
Resources Sponsored by: Eli Lilly and Company in partnership with Xcenda Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system. Sponsored by: Clarivate Analytics 18 high-value new licensing deals worth in excess of $500 million took place during the second quarter of 2019 -Get the Q2 2019 Biopharma licensing report for full details and insights. Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BBK Worldwide Get the latest data on how people are using apps to manage their health, and learn how you can leverage it in the development of your next clinical trial app. Sponsored by: Blue Latitude Health Report: How to design digital services that deliver value and improve outcomes for patients, healthcare professionals and the healthcare systems they serve Sponsored by: Article Galaxy powered by Reprints Desk This white paper examines the skyrocketing cost of drug development and provides step-by-step guidance for executing a successful fail fast strategy. Sponsored by: Outer Edge Technology Companies that don’t have a cloud strategy are at a competitive disadvantage. Why? The cloud has a measurable impact on business. Sponsored by: Colorcon® Learn about how you better manage product authentication and battle drug counterfeiting with innovative solutions. Sponsored by: Cortellis, a Clarivate Analytics Solution Download this report for full details of Life sciences M&As in the second quarter of 2019 with notes and trends. Sponsored by: Life Image The time has finally come when medical imaging can be effectively utilized into the RWE process. Read the whitepaper on the best practices for incorporating Real World Imaging.™ Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA Countdown to Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register Now at www.drugstomarket.com/drugbootcamp and start Pre-Boot Camp Preparation A Rare Affair for Rare Diseases January 12, 2020 | San Francisco, CA | 